サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1409744

禁煙補助薬の世界市場レポート 2024年

Quit Smoking Drugs Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
禁煙補助薬の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

禁煙補助薬の市場規模は近年急速に拡大しています。2023年の348億6,000万米ドルから2024年には396億9,000万米ドルに、CAGR13.8％で拡大します。過去の期間に観察された成長は、健康意識キャンペーン、医療処置の進歩、政府のイニシアティブ、行動療法の統合、禁煙に対する消費者の態度の変化などの要因に起因しています。

禁煙補助薬市場規模は、今後数年で急成長が見込まれます。2028年の年間平均成長率（CAGR）は14.9%で690億8,000万米ドルに成長します。予測期間中に予想される成長は、研究開発への投資の増加、禁煙補助薬への需要の高まり、ターゲットを絞ったマーケティングと啓発キャンペーン、禁煙のための薬物療法の進歩に起因すると考えられます。予測期間に予想される主な動向には、個別化治療アプローチの採用、健康意識の高まり、デジタル治療薬とアプリの統合、行動療法の取り込み、的を絞ったマーケティングと教育活動の継続的重視などがあります。

禁煙治療薬市場の成長は、喫煙に関連する様々な疾患の有病率の増加によって牽引されると予測されます。喫煙は、タバコ、マリファナ、ハシシなどの植物を燃やすことで発生する蒸気を吸ったり吐いたりすることであり、多くの健康問題を引き起こしています。禁煙補助薬は、タバコへの欲求に対処し、効果的な禁煙を助けることで、喫煙への衝動を抑える上で重要な役割を果たしています。例えば、2022年5月現在、世界保健機関（WHO）の報告によると、タバコの使用は年間800万人以上の死亡の原因となっており、そのうち120万人以上は副流煙にさらされた非喫煙者が原因となっています。米国だけでも、2021年に米国心臓協会が報告したように、喫煙に関連した心血管疾患が毎年48万人以上の成人の命を奪っています。したがって、喫煙関連疾患の有病率の増加は、禁煙補助薬市場を推進する重要な要因となっています。

禁煙補助薬市場の成長は、eコマースの台頭によってさらに加速すると予想されます。商品やサービスのオンライン売買を伴うeコマースは、禁煙ソリューションを求める個人に便利なプラットフォームを提供します。禁煙補助薬は、禁煙を目指す人々に控えめで使いやすい選択肢を提供し、オンライン・プラットフォームを通じてますますアクセスしやすくなっています。例えば、2023年8月、米国国勢調査局は、2023年第2四半期の米国小売eコマース売上高が2.1％増加し、2,776億米ドルに達すると推定しました。このeコマース活動の急増は、禁煙補助薬市場の拡大に寄与しています。

2023年の禁煙補助薬市場では北米が最大地域でした。禁煙補助薬市場レポートの対象地域は、アジア太平洋,西欧,東欧,北米,南米,中東,アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 禁煙補助薬市場の特徴

第3章 禁煙補助薬市場の動向と戦略

第4章 禁煙補助薬市場- マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の禁煙補助薬市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 禁煙補助薬市場セグメンテーション

  • 世界の禁煙補助薬市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 薬物セラピー
  • 電子タバコ
  • ニコチン吸入器
  • ニコチン代替療法
  • ニコチン舌下錠
  • 世界の禁煙補助薬市場、薬物別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • バレニクリン（チャンティクス）
  • ブプロピオン（ザイバン）
  • その他の薬物
  • 世界の禁煙補助薬市場、流通別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • ドラッグストア
  • オンライン薬局
  • 小売薬局

第7章 禁煙補助薬市場の地域および国分析

  • 世界の禁煙補助薬市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
  • 世界の禁煙補助薬市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋の禁煙補助薬市場

第9章 中国の禁煙補助薬市場

第10章 インドの禁煙補助薬市場

第11章 日本の禁煙補助薬市場

第12章 オーストラリアの禁煙補助薬市場

第13章 インドネシアの禁煙補助薬市場

第14章 韓国の禁煙補助薬市場

第15章 西欧の禁煙補助薬市場

第16章 英国の禁煙補助薬市場

第17章 ドイツの禁煙補助薬市場

第18章 フランスの禁煙補助薬市場

第19章 イタリアの禁煙補助薬市場

第20章 スペインの禁煙補助薬市場

第21章 東欧の禁煙補助薬市場

第22章 ロシアの禁煙補助薬市場

第23章 北米の禁煙補助薬市場

第24章 米国の禁煙補助薬市場

第25章 カナダの禁煙補助薬市場

第26章 南米の禁煙補助薬市場

第27章 ブラジルの禁煙補助薬市場

第28章 中東の禁煙補助薬市場

第29章 アフリカの禁煙補助薬市場

第30章 禁煙補助薬市場の競合情勢と企業プロファイル

  • 禁煙補助薬市場の競合情勢
  • 禁煙補助薬市場の企業プロファイル
    • 22nd Century Group
    • Alkalon A/S
    • Cipla Limited
    • Dr. Reddy's Laboratories
    • GSK Plc.

第31章 世界の禁煙補助薬市場の競合ベンチマーキング

第32章 世界の禁煙補助薬市場競争ダッシュボード

第33章 禁煙補助薬市場における主要な合併と買収

第34章 禁煙補助薬市場の将来展望と可能性分析

第35章 付録

目次
Product Code: r11282

“Quit Smoking Drugs Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on quit smoking drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for quit smoking drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The quit smoking drugs market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product: Drug Therapy; E-Cigarettes; Nicotine Inhalers; Nicotine Replacement Therapies; Nicotine Sublingual Tablets
  • 2) By Drug: Varenicline (Chantix); Bupropion (Zyban); Other Drugs
  • 3) By Distribution: Drug Store; Online Pharmacies; Retail Pharmacies
  • Companies Mentioned: 22nd Century Group; Alkalon A/S; Cipla Limited; Dr. Reddy's Laboratories; GSK Plc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Quit smoking drugs are specialized medications used by individuals aiming to quit smoking. These drugs help reduce cravings and alleviate nicotine withdrawal symptoms. They deliver nicotine in alternative forms, such as chewing gum or patches, for a limited period, thus mitigating withdrawal symptoms and the urge to smoke.

The major products within the category of quit-smoking drugs include drug therapy, electronic cigarettes, nicotine inhalers, nicotine replacement therapies, and nicotine sublingual tablets. Drug therapy involves the use of medications to treat or prevent diseases related to smoking cessation. Medications such as Varenicline (Chantix), Bupropion (Zyban), and others are available through various channels, including drug stores, online pharmacies, and retail pharmacies.

The quit smoking drugs market research report is one of a series of new reports from The Business Research Company that provides quit smoking drugs market statistics, including quit smoking drugs industry global market size, regional shares, competitors with a quit smoking drugs market share, detailed quit smoking drugs market segments, market trends and opportunities, and any further data you may need to thrive in the quit smoking drugs industry. This quit smoking drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The quit smoking drugs market size has grown rapidly in recent years. It will grow from $34.86 billion in 2023 to $39.69 billion in 2024 at a compound annual growth rate (CAGR) of 13.8%. The growth observed in the historical period can be attributed to factors such as health awareness campaigns, advancements in medical treatments, government initiatives, the integration of behavioral therapies, and shifts in consumer attitudes towards smoking cessation.

The quit smoking drugs market size is expected to see rapid growth in the next few years. It will grow to $69.08 billion in 2028 at a compound annual growth rate (CAGR) of 14.9%. The anticipated growth in the forecast period can be attributed to increased investments in research and development, a growing demand for cessation aids, targeted marketing and awareness campaigns, and advancements in pharmacotherapy for smoking cessation. Major trends expected in the forecast period include the adoption of personalized treatment approaches, a rise in health consciousness, the integration of digital therapeutics and apps, the incorporation of behavioral therapy, and the continued emphasis on targeted marketing and education efforts.

The growth of the market for quit-smoking drugs is anticipated to be driven by the increasing prevalence of various diseases associated with smoking. Smoking, the inhalation and exhalation of vapors from burning plant materials such as tobacco, marijuana, and hashish, contributes to numerous health issues. Quit-smoking drugs play a crucial role in reducing the urge to smoke by addressing cravings for tobacco and aiding in the effective cessation of smoking. For instance, as of May 2022, the World Health Organization (WHO) reported that tobacco use is responsible for more than 8 million deaths annually, with over 1.2 million fatalities attributed to non-smokers exposed to secondhand smoke. In the United States alone, cardiovascular disease linked to smoking claims the lives of over 480,000 adults each year, as reported by the American Heart Association in 2021. Thus, the growing prevalence of smoking-related diseases is a significant factor propelling the quit-smoking drug market.

The growth of the quit-smoking drugs market is expected to be further accelerated by the rise of e-commerce. E-commerce, involving the online buying and selling of goods and services, provides a convenient platform for individuals seeking quit-smoking solutions. Quit-smoking drugs are increasingly accessible through online platforms, offering a discreet and user-friendly option for those aiming to quit smoking. For example, in August 2023, the U.S. Census Bureau estimated a 2.1% increase in U.S. retail e-commerce sales for the second quarter of 2023, reaching $277.6 billion. This surge in e-commerce activities contributes to the expansion of the quit-smoking drugs market.

A key trend in the quit-smoking drugs market is the focus on product innovation by major companies to strengthen their market positions. Notably, Swedish Match AB, a tobacco company based in Sweden, introduced ZYN Tobacco Gold in August 2022. ZYN Tobacco Gold is a nicotine pouch with a sweet tobacco flavor, offering a tobacco-free and smoke-free alternative. This innovative product addresses consumer preferences for reduced-risk alternatives, catering to those who wish to avoid tobacco consumption while still enjoying a nicotine kick in smoke-free environments.

Major companies in the quit-smoking drugs market are also concentrating on the development of innovative products such as medicated nicotine lozenges to tackle the high mortality burden associated with smoking. Medicated nicotine lozenges, pharmaceutical products delivering controlled doses of nicotine through oral consumption, aim to assist individuals in quitting smoking by alleviating withdrawal symptoms and reducing the urge to smoke. In May 2021, JB Chemicals & Pharmaceuticals, based in India, launched NOSMOK medicated nicotine lozenges, available in mint flavor with sugar-based or sugar-free variants in 2mg and 4mg strengths. This initiative addresses the significant health and economic costs associated with tobacco use.

In September 2021, Philip Morris International Inc., a U.S.-based tobacco company, acquired Fertin Pharma for $820 million. This strategic acquisition is part of Philip Morris International Inc.'s goal to generate over 50% of its total net revenues from smoke-free products and a minimum of $1 billion in net revenues from products other than nicotine. Fertin Pharma, a Denmark-based pharmaceutical and nutraceutical product manufacturer, brings valuable technologies, expertise, and personnel to support Philip Morris International Inc.'s objectives in the quit-smoking products sector.

Major companies operating in the quit smoking drugs market report are 22nd Century Group, Alkalon A/S, Cipla Limited, Dr. Reddy's Laboratories, GSK Plc., Johnson & Johnson, NJOY LLC, Novartis AG, Perrigo Company Plc, Pfizer Inc., Philip Morris International, Laboratoires Pierre Fabre, Takeda Pharmaceutical Company, Glenmark Pharmaceuticals Limited, Zydus Cadila Healthcare Limited, Rusan Pharma Ltd., Axsome Therapeutics, BioCorRx Inc., BGP Pharma UAB, Bionorica SE, Cambrex Corporation, Chrono Therapeutics Inc., Coeptis Pharmaceuticals Inc., CV Sciences Inc., D-Pharm Ltd., DURECT Corporation, Egalet Corporation, Ennaid Therapeutics LLC, Fertin Pharma A/S, Gilla Inc., H&T Presspart Manufacturing Ltd., Hikma Pharmaceuticals PLC, Innovus Pharmaceuticals Inc., IntelGenx Technologies Corp

North America was the largest region in the quit smoking drugs market in 2023. The regions covered in the quit smoking drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the quit smoking drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The quit-smoking drugs market consists of sales of AXS-05, cytisincline, nadolol, and liraglutide. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Quit Smoking Drugs Market Characteristics

3. Quit Smoking Drugs Market Trends And Strategies

4. Quit Smoking Drugs Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Quit Smoking Drugs Market Size and Growth

  • 5.1. Global Quit Smoking Drugs Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Quit Smoking Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Quit Smoking Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Quit Smoking Drugs Market Segmentation

  • 6.1. Global Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Drug Therapy
  • E-Cigarettes
  • Nicotine Inhalers
  • Nicotine Replacement Therapies
  • Nicotine Sublingual Tablets
  • 6.2. Global Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Varenicline (Chantix)
  • Bupropion (Zyban)
  • Other Drugs
  • 6.3. Global Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Drug Store
  • Online Pharmacies
  • Retail Pharmacies

7. Quit Smoking Drugs Market Regional And Country Analysis

  • 7.1. Global Quit Smoking Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Quit Smoking Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Quit Smoking Drugs Market

  • 8.1. Asia-Pacific Quit Smoking Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Quit Smoking Drugs Market

  • 9.1. China Quit Smoking Drugs Market Overview
  • 9.2. China Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Quit Smoking Drugs Market

  • 10.1. India Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Quit Smoking Drugs Market

  • 11.1. Japan Quit Smoking Drugs Market Overview
  • 11.2. Japan Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Quit Smoking Drugs Market

  • 12.1. Australia Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Quit Smoking Drugs Market

  • 13.1. Indonesia Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Quit Smoking Drugs Market

  • 14.1. South Korea Quit Smoking Drugs Market Overview
  • 14.2. South Korea Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Quit Smoking Drugs Market

  • 15.1. Western Europe Quit Smoking Drugs Market Overview
  • 15.2. Western Europe Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Quit Smoking Drugs Market

  • 16.1. UK Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Quit Smoking Drugs Market

  • 17.1. Germany Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Quit Smoking Drugs Market

  • 18.1. France Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Quit Smoking Drugs Market

  • 19.1. Italy Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Quit Smoking Drugs Market

  • 20.1. Spain Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Quit Smoking Drugs Market

  • 21.1. Eastern Europe Quit Smoking Drugs Market Overview
  • 21.2. Eastern Europe Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Quit Smoking Drugs Market

  • 22.1. Russia Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Quit Smoking Drugs Market

  • 23.1. North America Quit Smoking Drugs Market Overview
  • 23.2. North America Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Quit Smoking Drugs Market

  • 24.1. USA Quit Smoking Drugs Market Overview
  • 24.2. USA Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Quit Smoking Drugs Market

  • 25.1. Canada Quit Smoking Drugs Market Overview
  • 25.2. Canada Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Quit Smoking Drugs Market

  • 26.1. South America Quit Smoking Drugs Market Overview
  • 26.2. South America Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Quit Smoking Drugs Market

  • 27.1. Brazil Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Quit Smoking Drugs Market

  • 28.1. Middle East Quit Smoking Drugs Market Overview
  • 28.2. Middle East Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Quit Smoking Drugs Market

  • 29.1. Africa Quit Smoking Drugs Market Overview
  • 29.2. Africa Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Quit Smoking Drugs Market Competitive Landscape And Company Profiles

  • 30.1. Quit Smoking Drugs Market Competitive Landscape
  • 30.2. Quit Smoking Drugs Market Company Profiles
    • 30.2.1. 22nd Century Group
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Alkalon A/S
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Cipla Limited
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Dr. Reddy's Laboratories
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. GSK Plc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Quit Smoking Drugs Market Competitive Benchmarking

32. Global Quit Smoking Drugs Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Quit Smoking Drugs Market

34. Quit Smoking Drugs Market Future Outlook and Potential Analysis

  • 34.1 Quit Smoking Drugs Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Quit Smoking Drugs Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Quit Smoking Drugs Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer